BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23532111)

  • 1. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey.
    Hasegawa K; Makuuchi M; Kokudo N; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y;
    Ann Surg; 2014 Jan; 259(1):166-70. PubMed ID: 23532111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification.
    Poon RT; Fan ST; Ng IO; Wong J
    Ann Surg; 2003 Mar; 237(3):376-83. PubMed ID: 12616122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
    Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy].
    Li BK; Cui BK; Yuan YF; Li JQ; Zhang YQ; Shi M; Li GH
    Ai Zheng; 2005 Jul; 24(7):769-73. PubMed ID: 16004798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
    Lei HJ; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    J Am Coll Surg; 2006 Oct; 203(4):426-35. PubMed ID: 17000385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Step classification is useful for the determination of indications for systematized hepatectomy in hepatocellular carcinoma.
    Ariizumi S; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    J Hepatobiliary Pancreat Surg; 2005; 12(5):371-7. PubMed ID: 16258805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection.
    Chiappa A; Zbar AP; Podda M; Audisio RA; Bertani E; Biella F; Paties C; Staudacher C
    Hepatogastroenterology; 2001; 48(37):229-34. PubMed ID: 11268972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of incorporation of model for end-stage liver disease score with TNM staging in patients with hepatocellular carcinoma undergoing hepatic resection.
    Ling CH; Chau GY; Hsia CY; King KL
    Hepatogastroenterology; 2013; 60(125):1142-7. PubMed ID: 23803377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome.
    Lee CW; Chan KM; Lee CF; Yu MC; Lee WC; Wu TJ; Chen MF
    Asian J Surg; 2011 Apr; 34(2):53-62. PubMed ID: 21723467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection for hepatocellular carcinoma.
    Nonami T; Harada A; Kurokawa T; Nakao A; Takagi H
    Am J Surg; 1997 Apr; 173(4):288-91. PubMed ID: 9136782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.